v3.26.1
Segment Data (Details)
 3 Months Ended
Mar. 31, 2026
USD ($)
Mar. 31, 2025
USD ($)
Segment
Dec. 31, 2025
USD ($)
Segment Information      
Number of reportable segments | Segment   2  
Right-of-use asset $ 1,079,000   $ 1,000,000
External revenue 20,272,000 $ 2,214,000  
Cost of revenue 1,158,000 515,000  
Research and development 3,928,000 3,730,000  
Sales and marketing 896,000 2,493,000  
General and administrative 4,108,000 4,897,000  
Interest 699,000 (56,000)  
Net comprehensive income (loss) 8,265,000 (10,858,000)  
Segment net loss 8,723,000 (10,596,000)  
Segment assets 37,434,000   38,323,000
Napo Therapeutics Lease Office | Europe      
Segment Information      
Right-of-use asset 157,000 87,000  
Property, Plant, and Equipment, Right-of-Use Assets, and Intangible Assets | US      
Segment Information      
Right-of-use asset 16,900,000   17,400,000
Product revenue, net      
Segment Information      
External revenue 1,204,000 2,171,000  
Operating Segments      
Segment Information      
External revenue 20,272,000 2,214,000  
Cost of revenue 1,158,000 515,000  
Research and development 3,923,000 3,725,000  
Sales and marketing 896,000 2,493,000  
General and administrative 4,613,000 5,342,000  
Interest 699,000    
Other segment items 1,386,000 1,487,000  
Segment expenses 12,675,000 13,562,000  
Net comprehensive income (loss) 7,597,000 (11,348,000)  
Segment assets 204,158,000   213,832,000
Operating Segments | Human Health      
Segment Information      
External revenue 19,927,000 2,138,000  
Cost of revenue 987,000 505,000  
Research and development 3,169,000 3,113,000  
Sales and marketing 704,000 2,396,000  
General and administrative 1,971,000 2,004,000  
Interest 187,000    
Other segment items 1,044,000 311,000  
Segment expenses 8,062,000 8,329,000  
Net comprehensive income (loss) 11,865,000 (6,191,000)  
Segment assets 30,692,000   28,321,000
Operating Segments | Animal Health      
Segment Information      
External revenue 345,000 76,000  
Cost of revenue 171,000 10,000  
Research and development 754,000 612,000  
Sales and marketing 192,000 97,000  
General and administrative 2,642,000 3,338,000  
Interest 512,000    
Other segment items 342,000 1,176,000  
Segment expenses 4,613,000 5,233,000  
Net comprehensive income (loss) (4,268,000) (5,157,000)  
Segment assets 173,466,000   185,511,000
Eliminations And Reconciling Items [Member]      
Segment Information      
Net comprehensive income (loss) 668,000 $ 490,000  
Segment Reconciling Items      
Segment Information      
Segment assets (29,231,000)   (29,231,000)
Intersegment Eliminations      
Segment Information      
Segment assets $ (137,493,000)   $ (146,278,000)